Publications Database

Delhey L. M. et al. (2017)

The effect of mitochondrial supplements on mitochondrial activity in children with autism spectrum disorder.

Journal of Clinical Medicine

6(2), pii: E18.

Read Abstract (New Window) Read Full (New Window)

Frye R. E. et al. (2013)

A review of traditional and novel treatments for seizures in autism spectrum disorder: Findings from a systematic review and expert panel.

Frontiers in Public Health

Read Abstract (New Window) Read Full (New Window)

Frye R. E. et al. (2013)

Cerebral folate receptor autoantibodies in autism spectrum disorder.

Molecular Autism

18 pp. 369–381.

Read Abstract (New Window)

Frye R. E. (2014)

Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder.

Drug, Healthcare and Patient Safety

6 pp. 69-76.

Read Abstract (New Window) Read Full (New Window)

Delhey L. M. et al. (2018)

Comparison of treatment for metabolic disorders associated with autism: Reanalysis of three clinical trials.

Frontiers in Neuroscience

2(19),

Read Abstract (New Window) Read Full (New Window)

Frye R. E. et al. (2013)

Effectiveness of methylcobalamin and folinic acid treatment on adaptive behavior in children with autistic disorder Is related to glutathione redox status.

Autism Research and Treatment

Read Full (New Window)

Frye R. E. et al.

Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.

Molecular Psychiatry

Read Full (New Window)

Frye R. E. , Rossignol D. A. (2016)

Identification and treatment of pathophysiological comorbidities of autism spectrum disorder to achieve optimal outcomes.

Clinical Medicine Insights: Pediatrics

Read Abstract (New Window) Read Full (New Window)

Frye R. E. et al. (2013)

Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study.

Transcultural Psychiatry

3 e237.

Read Full (New Window)

Frye R. E. , Huffman L. , Elliott G. R. (2010)

Tetrahydrobiopterin as a novel therapeutic intervention for autism.

Neurotherapeutics

7(3), pp. 241-249

Read Abstract (New Window) Read Full (New Window)

Frye R. E. , Sreenivasula S. , Adams J. B. (2011)

Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey.

BMC Pediatrics

11(1), pp. 37

Read Abstract (New Window) Read Full (New Window)

Frye R. E. , Rossignol D. A. (2014)

Treatments for biomedical abnormalities associated with autism spectrum disorder.

Frontier in Pediatrics

eCollection 2014.

Read Abstract (New Window) Read Full (New Window)

Rossignol D. A. , Frye R. E. (2012)

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures

Molecular Psychiatry

17 pp. 389-401

Read Full (New Window)

Rossignol D. A. et al. (2012)

Hyperbaric oxygen treatment in autism spectrum disorders.

Medical Gas Research

15(2), pp. 16

Read Abstract (New Window) Read Full (New Window)

Rossignol D. A. , Frye R. E. (2014)

Melatonin in autism spectrum disorders.

Current Clincial Pharmacology

9(4), pp. 326-334.

Read Abstract (New Window)

Rossignol D. A. , Frye R. E. (2011)

Melatonin in autism spectrum disorders: a systematic review and meta-analysis.

Developmental Medicine and Child Neurology

53(9), pp. 783-792

Read Abstract (New Window)

Rossignol D. A. , Frye R. E. (2012)

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.

Molecular Psychiatry

17(3), pp. 290-314.

Read Abstract (New Window)

Rossignol D. A. , Frye R. E. (2014)

The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review.

Frontier in Pediatrics

August, 2

Read Abstract (New Window) Read Full (New Window)